Simultaneous inhibition of the constitutively activated nuclear factor kappaB and of the interleukin-6 pathways is necessary and sufficient to completely overcome apoptosis resistance of human U266 myeloma cells.

Source:http://linkedlifedata.com/resource/pubmed/id/18931595

Download in:

View as

General Info

PMID
18931595